In controls, the CSF:serum APRIL ratio was 5.8-fold higher than the CSF:serum BAFF ratio (P  <  0.0001); in untreated OMS, it was 2.8-fold higher (P  <  0.0001). This evidence concerns the gene TNFSF13 and opsoclonus-myoclonus syndrome.